Viking Therapeutics VKTX
NASDAQ VKTX
$25.83 -0.55 (-2.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Accumulated Expenses (2014 - 2018)

Updated

Analysis

Viking Therapeutics (VKTX) Accumulated Expenses (2014 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Viking Therapeutics 2.99 Bn 464.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 34,000.00
Dec 31, 2017 22,000.00
Sep 30, 2017 9,982.00
Jun 30, 2017 59,333.00
Dec 31, 2016 34,894.00
Sep 30, 2016 22,674.00
Jun 30, 2016 10,455.00
Sep 30, 2015 152,361.00
Jun 30, 2015 121,111.00
Mar 31, 2015 112,475.00
Dec 31, 2014 77,222.00
API Access

Viking Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY